PUBLICATIONS
As shown below, our work has been highlighted in a number of high impact peer reviewed journals and mainstream media publications (including the Washington Post, National Post and TCT MD.
Publications (Underline: Student Co-Authors) 2024 (5) Parent, S., Vaka, R., St Amant, J., Khan, S., Van Remortel, S., Bi, C., Courtman, D., Stewart, D.J., Davis, D.R., Inactivation of the NLRP3 inflammasome mediates exosome-based prevention of atrial fibrillation. Theranostics. 14(2): 608-621. 2024. Smith, C., Lalu, M.M., Davis, D.R., Exploring Patient Viewpoints to Optimize Implementation of Biological Therapy for Atrial Fibrillation Prevention, CJC Open. 2024. (in press) Ahmed, N., Davis, D.R., RNA and the emerging potential of bio-inspired molecules in cardiovascular disease therapies, European Heart Journal. 2024 (in press). Van Remortel, S., Risha, Y., Parent, S., Nair, V., Birnie, D.H., Davis, D.R., Development of a Mouse Cardiac Sarcoidosis Model Using Carbon Nanotubes, Advanced Biology, 2024 (in press). Parent, S., St Amant, J., Van Remortel, S., Kahn, S., Vaka, R., Courtman, D., Stewart, D.J., Davis, D.R., Atrial Fibrosis and Inflammation in Postoperative Atrial Fibrillation: Comparative Effects of Amiodarone, Colchicine, or Exosomes, JACC: Clinical Electrophysiology. 2024 (in press). 2023 (8) Parent, S., Vaka, R., Risha, Y., Ngo, C., Kanda, P., Nattel, S., Khan, S., Courtman, D., Stewart, D.J., Davis, D.R., Prevention of atrial fibrillation after open chest surgery with extracellular vesicle therapy. JCI Insight. 8(15):e167440, 2023. Vaka, R., Parent, S., Risha, Y., Khan, S., Courtman, D., Stewart, D.J., Davis, D.R., Extracellular vesicle microRNA and protein cargo profiling in three clinical-grade stem cell products reveals key functional pathways. Molecular Therapy Nucleic Acids 32: 80–93, 2023. Malhotra, K., Van Remortel, S., Ly, V., Davis, DR., Combinatorial effect of biomaterials and extracellular vesicle therapy for heart failure with reduced ejection fraction: a systematic review of preclinical studies. Advanced Healthcare Materials 2301980, 2023 Thibert, M.J., Odabashian, R., Lepage-Ratte, M.F., Jones, A., Alqarawi, W., Nery, P.B., Nair, G., Davis, D.R., Golian, M., Redpath, C.J., Hansom, S., Ramirez, F.D., Aydin, A., Klein, A., Green, M.S., Birnie, D.H., Sadek, M.M., How much endocardial scar homogenization is required for successful ablation of ischemic ventricular tachycardia? Heart Rhythm. 20 (10): 1418-1419 2023. Dutcher M., Chewchuk S., Benavente-Babace A., Soucy N., Wan F., Merrett K., Davis D.R., Harden J.L., Godin M., Encapsulating Therapeutic Cells in RGD-Modified Agarose Microcapsules. Biomedical Materials. 18(5): 055007, 2023. Weng W., Birnie D.H., Ramirez F.D., Van Stiphout C., Golian M., Nery P.B., Hansom S.P., Redpath C.J., Klein A., Nair G.M., Alqarawi W., Green M.S., Davis D.R., Santangeli P., Schaller R.D., Marchlinski F.E., Sadek M.M.. Outcomes of a comprehensive strategy during repeat atrial fibrillation ablation. J Interv Card Electrophysiol. 65(2): 391-399, 2023. Lu A, Gu R, Chu C, Xia Y, Wang J, Davis DR, Liang W. Inhibition of Wnt/β-catenin signaling upregulates Nav 1.5 channels in Brugada syndrome iPSC-derived cardiomyocytes. Phys Rep. 11(10): e15696. 2023. Collet, B., Davis, D.R., Mechanisms of Cardiac Repair in Cell Therapy, Heart, Lung Circulation 32(7): P825-835, 2023. 2022 (7) Weng W, Theriault-Lauzier P, Birnie D, Redpath C, Golian M, Sadek MM, Klein A, Ramirez FD, Davis DR, Nery PB, Nair GM, Hansom S, Green MS, Aydin A. Should they stay, or should they go: Do we need to remove the old cardiac implantable electronic device if a new system is required on the contralateral side? Heart Rhythm O2. 3(2):169-175. 2022. Lu A, Wang J, Xia Y, Gu R, Kim KH, Mulvihill EE, Davis DR, Beanlands RS, Liang W. Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk. J Vis Exp. 185. 2022. Muñoz M, Eren Cimenci C, Goel K, Comtois-Bona M, Hossain M, McTiernan C, Zuñiga-Bustos M, Ross A, Truong B, Davis DR, Liang W, Rotstein B, Ruel M, Poblete H, Suuronen EJ, Alarcon EI. Nanoengineered Sprayable Therapy for Treating Myocardial Infarction. ACS Nano 16 (3): 3522–3537, 2022. Vaka, R., Van Remortel, S., Ly, V., Davis, D.R. Extracellular vesicle therapy for non-ischemic heart failure: a systematic review of preclinical studies. Extracellular Vesicles 1: 100009, 2022. McLaughlin, S., Sedlakova, V., Zhang, Q., McNeill, B., Smyth, D., Seymour, R., Davis, D.R., Ruel, M., Brand, M., Alarcon, E.I., Suuronen, E.J., Recombinant human collagen hydrogel rapidly reduces methylglyoxal adducts within cardiomyocytes and improves border zone contractility after myocardial infarction in mice. Adv Funct Mater 2022 Davis, D.R., Cell therapy for patients with Duchenne Muscular Dystrophy. Lancet 12; 399(10329):1024-1025, 2022. Vaka, R, Khan, S, Ye, B, Risha, Y, Parent, S, Courtman, D., Stewart, D.J., Davis, D.R., Direct comparison of different therapeutic cell types for COVID-19 acute lung injury. Stem Cell Research and Therapy 13:20, 2022. 2021 (4) Vaka, R., Davis, D.R., State-of-play for cellular therapies in cardiac repair and regeneration. Stem Cells 39:1579–1588, 2021. Vigneault, P., Parent, S., Kanda, P., Michie, C., Nattel, S., Davis D.R., Electrophysiological engineering of heart-derived cells with calcium-dependent potassium channels improves cell therapy efficacy for cardioprotection. Nature Communications 12(1):4963, 2021. Wang, J., Xia, Y., Lu, A., Wang, H., Davis D.R., Liu, P., Beanlands, R.S., Liang, W. Cardiomyocyte-specific deletion of β-catenin protects mouse hearts from ventricular arrhythmias after myocardial infarction. Sci Rep. 11(1):17722, 2021. Hansom, S.P., Alqarawi, W., Birnie, D.H., Golian, M., Nery, P.B., Redpath, C.J., Klein, A., Green, M.S., Davis, D.R., Sheppard-Perkins, E., Ramirez, F.D., Nair, G.M., Sadek, M.M. High-power, short-duration atrial fibrillation ablation compared with a conventional approach: Outcomes and reconnection patterns. J Cardiovasc Electrophysiol. 32(5):1219-1228, 2021. 2020 (3) Rafatian, G., Kamkar, M., Parent, S., Michie, C., Risha, Y., Molgat, A.S.D., Seymour, R., Suuronen, E.J., Davis, D.R., Mybl2 rejuvenates heart explant-derived cells from aged donors after myocardial infarction. Aging Cell. doi.org/10.1111/acel.13174 Kanda, P., Benavente-Babace, A., Parent, S., Michie, C., Soucy, N., Steeves, A., Lu, A., Cober, N.D., Courtman, D., Variola, F., Alarcon, E.I., Liang, W., Stewart, D.J., Godin, M., Davis, D.R., Deterministic paracrine repair of injured myocardium using microfluidic-based cocooning of heart explant-derived cells. Biomaterials. doi.org/10.1016/j.biomaterials.2020.120010 Davis, D.R., The cell engraftment hypothesis of cardiac repair. Current Stem Cell Research & Therapy. doi.org/10.2174/1574888x15666200206103005 2019 (11) Liang, W., Al Qarawi, W., Davis, D.R., Disease modeling and precision medicine using Canadian cardiomyocytes. Canadian Journal of Cardiology. doi.org/10.1016/j.cjca.2019.10.036 Alqarawi, W., Sadek, M., Golian, M., Hibbert, B., Redpath, C., Nair, G., Nery, P., Davis, D.R., Klein, A., Birnie, D.H., Green, M.S. A New electrocardiographic definition of left bundle branch block in patients after transcatheter aortic valve replacement. Journal of Electrocardiography. doi.org/10.1016/j.jelectrocard.2019.10.005 Mount, S., Kanda, P., Parent, S., Khan, S., Michie, C., Davila, L., Chan, V., Davies, R.A., Haddad, H., Courtman, D., Stewart, D.J., Davis, D.R., Physiologic expansion of human heart-derived cells enhances therapeutic repair of injured myocardium. Stem Cell Research and Therapeutics. doi.org/10.1186/s13287-019-1418-3 Alqarawi, W,, Coppens, J., Aldawood, W., Ramirez, F.D., Redpath, C.J., Nair, G.M., Nery, P.B., Davis, D.R., Abu Shama, R., Aydin, A., Klein, A., Golian, M., Schaller, R.D., Green, M.S., Birnie, D.H., Sadek, M.M., A strategy of lead abandonment in a large cohort of patients with sprint fidelis leads. JACC: Clinical Electrophysiology. http://doi.org/10.1016/j.jacep.2019.07.006 Kanda, P., Parent, S., Davis, D.R., Immortalized factories of therapeutic vesicles. Nature Biomedical Engineering. doi.org/10.1038/s41551-019-0453-9 Tzou, W.S., Hussein, A.A., Madhavan, M., Viswanathan, M.N., Steinberg, B.S., Ceresnak, S.R., Davis, D.R., Park, D.S., Wang, P.J., Kapa, S., Year in review in cardiac electrophysiology. Circulation Arrhythmia and Electrophysiology. doi.org/10.1161/CIRCEP.118.006648 Villanueva, M., Michie, C., Kanaan, G.N., Rafatian, G., Kanda, P., Ye, B., Liang, W., Harper, M-E., Davis, D.R., Glyoxalase 1 prevents chronic hyperglycemia induced heart-explant derived cell dysfunction. Theranostics. http://doi.org/10.7150/thno.36639 Davis, D.R., Paracrine heart repair comes of age. Canadian Journal Cardiology. doi.org/10.1016/j.cjca.2019.07.006 McRae, C., Kapoor, A., Kanda, P., Hibbert, B., Davis, D.R., Systematic review of biological therapies for atrial fibrillation. Heart Rhythm. doi.org/10.1016/j.hrthm.2019.03.021 Liang, W., Gasparyan, L., Al Qarawi, W., Davis D.R., Disease modeling of cardiac arrhythmias using human induced pluripotent stem cells. Expert Opinion Biological Therapies. doi.org/10.1080/14712598.2019.1575359 Davis, D.R., Heart stem cells in the post-Anversa era. European Heart Journal. doi.org/10.1093/eurheartj/ehz098 2018 (7) Hosoyama, K., Ahumada, M., McTiernan, C., Davis, D.R., Variola, F., Ruel, M., Liang, W., Suuronen, E., Alarcon, E. Nanoengineered electroconductive collagen-based cardiac patch for infarcted myocardium repair. ACS Applied Material Interfaces. doi.org/10.1021/acsami.8b18844 Ramirez, F.D., Sadek, M.M., Boileau, I., Cleland, M., Nery, P.B., Nair, G.M., Redpath, C.J., Green, M.S., Davis, D.R., Charron, K., Henne, J., Zakutney, T., Beanlands, R.S.B., Hibbert, B., Wells, G.A., Birnie, D.H. Evaluation of a novel cardioversion intervention for atrial fibrillation: the Ottawa AF cardioversion protocol. Europace. doi.org/10.1093/europace/euy285 Rafatian, G., Davis, D.R., Heart-Derived Cell Therapy 2.0: Paracrine strategies to increase therapeutic repair of injured myocardium. Stem Cells. doi.org/10.1002/stem.2910 Kapa, S., Davis, D.R., Park, D.S., Steinberg, B.A., Viswanathan, M.N., Tzou, W., Malini, M. Ceresnak, S.R., Wang, P.J., The year in review in cardiac electrophysiology. Circulation Arrhythmia and Electrophysiology. doi.org/10.1161/CIRCEP.118.007142 Alqarawi, W., Birnie, D.H., Spence, S, Ramirez, D., Redpath, C.J., Lemery, R., Nair, G.M., Nery, P.B., Davis, D.R., Green, M., Beauchesne, L., Chan, K., Ascah, K., Burwash, I., Sadek, M.M. Prevalence of left atrial appendage thrombus detected by transoesophageal echocardiography before catheter ablation of atrial fibrillation in patients anticoagulated with non-vitamin K antagonist oral anticoagulants. Europace. doi.org/10.1093/europace/euy129 Vigneault, P., Naud, P., Qi, X., Xiao, J., Villeneuve, L., Davis, D.R., Nattel, S. Calcium-Dependent Potassium Channels Control Proliferation of Cardiac Progenitor Cells and Bone Marrow-derived Mesenchymal Stem Cells. Journal of Physiology. doi.org/10.1113/JP275388 Kanda, P., Alarcon, E.I., Yeuchyk, T., Parent, S., deKemp, R.A., Variola, F., Courtman, D., Stewart, D.J., Davis, D.R., Deterministic micro-encapsulation of human cardiac stem cells in variable composition nanogel cocoons to enhance therapeutic regeneration of injured myocardium. ACS Nano. doi.org/10.1021/acsnano.7b08881 2017 (5) Rafatian, G., Davis, D.R., The frustration and futility of intra-coronary stem cell therapy. Canadian Journal of Cardiology. doi.org/10.1016/j.cjca.2017.09.023 Mayfield, A.E., Dixit, S., Kanda, P., Nantsios, A., Parent, S., Mount, M., Ye, B., Seymour, R., Stewart, D.J., Davis, D.R., Interleukin-6 mediates post-infarct repair by cardiac explant-derived stem cells. Theranostics. doi.org/10.7150/thno.19435 Kanda, P., Davis, D.R., Cellular mechanisms underlying cardiac engraftment of stem cells. Expert Opinion on Biological Therapies. doi.org/10.1080/14712598.2017.1346080 Liang, W., Lu, A., Davis, D.R., Induced pluripotent stem cell-based treatment of acquired heart block. The battle for tomorrow has begun! Circulation Arrhythmia and Electrophysiology. doi.org/10.1161/CIRCEP.117.005331 Jackson, R., Mount,S., Ye, B., Mayfield, A.E., Chan, V., Boodhwani, M., Davies, R.A., Haddad, H., Davis, D.R., Isolation of human cardiac explant derived stem cells from cryopreserved heart tissue. PLoS ONE. doi.org/10.1371/journal.pone.0176000 2016 (5) Mayfield, A., Fitzpatrick, M., Dixit, S., Latham, N., Tilokee, E.L., Villanueva, M., Mount, S., Lam, B.K., Ruel, M., Stewart, D.J., Davis, D.R., Patient risk for future cardiac events negatively predicts the regenerative capacity of explant-derived cardiac stem cells. Stem Cell Research and Therapeutics. doi.org/10.1186/s13287-016-0321-4 Essebag, V., Verma, A., Healey, J.S., Krahn, A.D., Kalfon, E., Coutu, B., Ayala-Paredes, F., Tang, A.S.L., Sapp, J., Sturmer, M., Keren, A., Wells, G.A., Birnie, D.H.; BRUISE CONTROL Investigators. Clinically significant pocket hematoma increases long-term risk of device infection. JACC. doi.org/10.1016/j.jacc.2016.01.009 Tilokee, E.L., Latham, N., Jackson, R., Ye, B., Lam, B.K., Ruel, M., Suuronen, E., Stewart, D.J., Davis D.R., Paracrine engineering of human cardiac stem cells to over-express stromal-cell derived factor 1α for enhanced myocardial repair. Stem Cells. doi.org/10.1002/stem.2373 Adler A., Sadek M.M., Chan A.Y., Dell E., Rutberg J., Davis D., Green M.S., Spears D.A., Gollob M.H., Patient outcomes from a specialized inherited arrhythmia clinic. Circulation Arrhythmia and Electrophysiology. doi.org/10.1161/CIRCEP.115.003440 Mount, S., Davis, D.R., Electrical effects of stem cell transplantation for ischaemic cardiomyopathy: Friend or Foe? Journal of Physiology. doi.org/10.1113/JP270540 2015 (1) Jackson, R., Tilokee, E.L., Latham, N., Ye, B., Boodhwani, M., Chan, V., Suuronen, E., Stewart, D.J., Davis, D.R., Paracrine engineering of human cardiac stem cells with insulin-like growth factor-1 attenuates cell death and enhances myocardial repair after intra-myocardial injection. JAHA. doi.org/10.1161/JAHA.115.002104 2014 (7) Molgat, ASD, Tilokee, E.L., Rafatian, G., Vulesevic, B., Ruel, M., Milne, R., Suuronen, E.J., Davis, D.R., Hyperglycemia inhibits cardiac stem cell-mediated cardiac repair and angiogenic capacity. Circulation. doi.org/10.1161/CIRCULATIONAHA.113.007908 Mayfield, A., Tilokee, E.L., Davis D.R., Resident cardiac stem cells and their role in stem cell therapeutics for myocardial repair. Canadian Journal of Cardiology. doi.org/10.1016/j.cjca.2014.03.018 Nery, P.B., Beanlands, R.S., Nair, G.N., Green, M.S., Yang, J., Mc Ardle, B.A., Davis, D.R., Gollob, M.H., Leung, E., Healey, J., Birnie, D.H., Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. Journal of Cardiac Electrophysiology. doi.org/10.1111/jce.12401 Ahmadi, A., McNeill, B., Vulesevic, B., Kordos, M., Mesana, T., Thorn, S., Renaud, J.M., Manthorp, E., Kuraitis, D., Toeg, H., Padavan, D.T., Mesana, T.G., Davis, D.R., Beanlands, R.S., DaSilva, J.N., deKemp, R.A., Ruel, M., Suuronen, E.J., The role of integrin α2 in cell and matrix therapy that improves perfusion, viability and function of infarcted myocardium. Biomaterials. doi.org/10.1016/j.biomaterials.2014.02.028 Yilbas, A.E., Hamilton, A., Wang, Y., Mach, H., Lacroix, N., Davis, D.R., Chen, J., Li, Q., Activation of GATA4 gene expression at the early stage of cardiac specification. Frontiers in Chemistry. doi.org/10.3389/fchem.2014.00012 Mayfield, A., Tilokee, E.L., McNeil, B., Lam, B.K., Ruel, M., Suuronen, E.J., Courtman, D.W., Stewart, D.J., Davis, D.R., The effect of encapsulation of cardiac stem cells within matrix-enriched hydrogel capsules on cell survival, post-ischemic cell retention and cardiac function. Biomaterials. doi.org/10.1016/j.biomaterials.2013.09.085 2013 (4) Latham, N., Ye, B., Jackson, R., Lam, B., Kuriatis, D., Ruel, M., Suuronen, E.J., Stewart, D.J., Davis, D.R., Human blood and cardiac stem cells synergize to enhance cardiac repair when co-transplanted into ischemic myocardium. Circulation. doi.org/10.1161/CIRCULATIONAHA.112.000374 Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, Simpson CS, Ayala-Paredes F, Coutu B, Leiria TL, Essebag V; BRUISE CONTROL Investigators. Pacemaker or defibrillator surgery without interruption of anticoagulation. NEJM. doi.org/10.1056/NEJMoa1302946 Tilokee, E., Davis, D.R., Circulating progenitor cells as a heart failure biomarker: Does a failing marrow predict a failing heart? Canadian Journal of Cardiology. doi.org/10.1016/j.cjca.2012.09.011 White, A.J., Matsushita, S., Chakravarty, T., Czer, L.S., Burton, K., Scwartz, E.R., Davis, D.R., Simsir, S., Reinsmoen, N.L., Forrester, J.S., Marbán, E., Makkar, R., Intrinsic cardiac origin of human cardiosphere-derived cells. European Heart Journal. doi.org/10.1093/eurheartj/ehr172 2012 (5) Davis, D.R., Stewart, D.J., Selectins for cardiosphere culture- The ‘Es’ have it! Molecular Therapy. doi.org/10.1038/mt.2012.120 Barth A.S., Zhang Y., Li T-S, Smith R.R., Chimenti I., Terrovitis J., Davis D.R., Kizana E., Ho A.S., O'Rourke B., Wolff A.C., Gerstenblith G., Marbán E., Functional impairment of human resident cardiac stem cells contributes to trastuzumab cardiotoxicity. Stem Cells Translational Medicine. doi.org/10.5966/sctm.2011-0016 Al Habashi, Y., Davis D.R. Superior Vena Cava Obstruction due to Pacemaker Leads. Europace. doi.org/10.1093/europace/eus029 Lortie M. DaSilva J.N., Kenk M., Thorn S., Davis D.R., Birnie, D.H., Beanlands R.S., deKemp, R.A. Analysis of (R)- and (S)-[11C]rolipram kinetics in canine myocardium for the evaluation of phosphodiesterase-4 with PET. Molecular Imaging Biology. doi.org/10.1007/s11307-011-0482-6 Al Habashi, Y., Kass, M., Green M.S., Davis D.R., Posterior His location in structural normal hearts. Canadian Journal of Cardiology. doi.org/10.1016/j.cjca.2010.12.005 2011 (1) Davis, D.R., Stewart, D.J. Autologous stem cells for myocardial repair. Expert Opinion in Biological Therapies. doi.org/10.1517/14712598.2011.556615 2010 (5) Li, T., Lee, S., Matsushita S., Davis D.R., Zhang, Y., Ruckdeschel Smith, R., Burton K., Marbán, E., Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair. Stem Cells. doi.org/10.1002/stem.532 Jiang, D., Jones, P., Davis, D.R., Gow, R., Green, M.S., Birnie, D.H., Chen, S.R.W. and Gollob, M.H. Identification and characterization of a novel cardiac ryanodine receptor mutation linked to catecholaminergic polymorphic ventricular tachycardia, Channels. doi.org/10.4161/chan.4.4.12666 Hibbert B., Hibbert R., Lim T.W., Green M.S., Gollob M.H., Davis D.R., Ventricular tachycardia following tube thoracotomy. Europace. doi.org/10.1093/europace/euq172 Cheng K, Li TS, Malliaras K, Davis D, Zhang Y, Marbán E. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circulation Research. doi.org/10.1161/CIRCRESAHA.109.212589 Davis, D.R., Kizana, E., Terrovitis, I., Barth, A.S., Smith, R., Miake, J. and Marbán, E., Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies. Journal of Cellular and Molecular Cardiology. doi.org/10.1016/j.yjmcc.2010.02.019 Davis, D.R., Smith, R., and Marbán, E., Human Cardiospheres are a Source of Stem Cells with Cardiomyogenic Potential. Stem Cells. doi.org/10.1002/stem.413 2009 (1) Davis, D.R., Zhang, Y., Smith, R.R., Cheng, K., Terrovitis, J., Li, T., Malliaras K., White, A., Marbán, E., Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS ONE. doi.org/10.1371/journal.pone.0007195 |